Evidence map›Paper›PMID 37488327›Full record

ArticleJournal of pharmacokinetics and pharmacodynamics2023

Generation and application of avatars in pharmacometric modelling.

Estelle Chasseloup, Andrew C Hooker, Mats O Karlsson

Abstract read
In one paragraph

Article in Journal of pharmacokinetics and pharmacodynamics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Digital Twin Technology In Radiology.Journal of imaging informatics in medicine · 2026
    Review
  2. What Is a Digital Twin in QSP, and Are We Doing It Right?CPT: pharmacometrics & systems pharmacology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Digital twins in medicine.Nature computational science · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Estelle ChasseloupDepartment of Pharmacy, Uppsala University, Box 580, Uppsala, 75123, Sweden.
Andrew C HookerDepartment of Pharmacy, Uppsala University, Box 580, Uppsala, 75123, Sweden.
Mats O KarlssonDepartment of Pharmacy, Uppsala University, Box 580, Uppsala, 75123, Sweden. mats.karlsson@farmaci.uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simulations from population models have critical applications in drug discovery and development. Avatars or digital twins, defined as individual simulations matching clinical criteria of interest compared to observations from a real subject within a predefined margin of accuracy, may be a better option for simulations performed to inform future drug development stages in cases where an adequate model is not achievable. The aim of this work was to (1) investigate methods for generating avatars with pharmacometric models, and (2) explore the properties of the generated avatars to assess the impact of the different selection settings on the number of avatars per subject, their closeness to the individual observations, and the properties of the selected samples subset from the theoretical model parameters probability density function. Avatars were generated using different combinations of nature and number of clinical criteria, accuracy of agreement, and/or number of simulations for two examples models previously published (hemato-toxicity and integrated glucose-insulin model). The avatar distribution could be used to assess the appropriateness of the models assumed parameter distribution. Similarly it could be used to assess the models ability to properly describe the trajectories of the observations. Avatars can give nuanced information regarding the ability of a model to simulate data similar to the observations both at the population and at the individual level. Further potential applications for avatars may be as a diagnostic tool, an alternative to simulations with insurance to replicate key clinical features, and as an individual measure of model fit.

Indexed as

AvatarsClinical endpointDigital twinsPharmacometricsVirtual twins

Identifiers

PMID37488327
PMCPMC10460751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.